ENFN - Enfusion, Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Cash flows from operating activities
Net Income
-7,654
-7,654
-282,242
4,061
12,656
Depreciation & amortization
6,344
6,344
3,975
2,291
1,157
Stock based compensation
24,993
24,993
289,803
-
0
Change in working capital
-5,600
-5,600
-14,741
-5,758
-1,798
Accounts receivable
-9,031
-9,031
-7,493
-4,216
-2,790
Accounts Payable
-843
-843
2,044
41
231
Other working capital
6,225
6,225
-8,332
-3,403
7,877
Other non-cash items
283
283
222
60
22
Net cash provided by operating activites
14,156
14,156
-318
1,665
12,306
Cash flows from investing activities
Investments in property, plant and equipment
-7,931
-7,931
-8,014
-5,068
-4,429
Net cash used for investing activites
-7,931
-7,931
-8,014
-5,068
-4,429
Cash flows from financing activities
Debt repayment
0
0
-100,000
-2,100
-2,000
Common stock issued
0
0
260,545
-
0
Common stock repurchased
0
0
-87,846
-76,634
-57,450
Dividends Paid
0
0
-3,283
-4,612
-11,011
Other financing activites
-7,959
-7,959
-10,567
-71,367
-24,087
Net cash used privided by (used for) financing activities
-7,959
-7,959
58,849
11,559
-7,541
Net change in cash
-1,820
-1,820
50,427
8,040
250
Cash at beginning of period
64,365
64,365
13,938
5,898
5,648
Cash at end of period
62,545
62,545
64,365
13,938
5,898
Free Cash Flow
Operating Cash Flow
14,156
14,156
-318
1,665
12,306
Capital Expenditure
-7,931
-7,931
-8,014
-5,068
-4,429
Free Cash Flow
6,225
6,225
-8,332
-3,403
7,877